Therapeutic antibodies: A new era in the treatment of respiratory diseases?

Sécher, T; Guilleminault, L; Reckamp, K; Amanam, I; Plantier, L; Heuzé-Vourc'h, N

Sécher, T; Guilleminault, L; Reckamp, K; Amanam, I; Plantier, L; Heuzé-Vourc'h, N.

Afiliação

Sécher T; INSERM, Centre d'Etude des Pathologies Respiratoires, U1100, F-37032 Tours, France; Université François Rabelais de Tours, F-37032 Tours, France.
Guilleminault L; Pôle des Voies respiratoires, Hôpital Larrey, CHU de Toulouse, F-31059 Toulouse, France; STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm, UPS, F-31013 Toulouse, France.
Reckamp K; City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Amanam I; City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Plantier L; INSERM, Centre d'Etude des Pathologies Respiratoires, U1100, F-37032 Tours, France; Université François Rabelais de Tours, F-37032 Tours, France; CHRU de Tours, Service de Pneumologie, F-37000 Tours, France.
Heuzé-Vourc'h N; INSERM, Centre d'Etude des Pathologies Respiratoires, U1100, F-37032 Tours, France; Université François Rabelais de Tours, F-37032 Tours, France. Electronic address: nathalie.vourch@univ-tours.fr.

Pharmacol Ther ; 189: 149-172, 2018 09.

Article em En | MEDLINE | ID: mdl-29730443

Assuntos

Anticorpos/uso terapêutico; Doenças Respiratórias/tratamento farmacológico; Animais; Humanos

Palavras-chave

Antibody; Asthma; Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis; Lung cancer; Respiratory infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Respiratórias / Anticorpos Limite: Animals / Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google